Keyphrases
Left Ventricular Function
100%
End-systolic Pressure
100%
Severe Heart Failure
100%
Inotropic Effect
100%
Pressure Transient Analysis
100%
Enoximone
100%
Left Ventricular End-diastolic Pressure
66%
Catheter
16%
Systolic Blood Pressure
16%
Coronary Artery Disease
16%
Maximal Rate
16%
Ejection Fraction
16%
New York Heart Association Class
16%
Angina
16%
Mean Dose
16%
Mean Arterial Pressure
16%
Heart Rate
16%
Ischemia
16%
Left Ventricular Volume
16%
Intravenous Administration
16%
Nitroprusside
16%
Vasodilator
16%
Pressure-volume
16%
Gated Blood Pool Imaging
16%
Inotropic Drugs
16%
Positive Inotropic Effect
16%
Left Ventricular End-diastolic Volume (LVEDV)
16%
Phosphodiesterase Inhibitors
16%
Contractile Function
16%
Preload
16%
End-systolic Pressure-volume Relation
16%
Afterload
16%
Micromanometer
16%
Pressure-volume Loop
16%
Pressure-volume Relationship
16%
Load-independent
16%
Myocardial Oxygen Consumption
16%
Pressure Evolution
16%
Medicine and Dentistry
Systolic Blood Pressure
100%
Congestive Heart Failure
100%
Inotropism
100%
Enoximone
100%
Heart Left Ventricle Pressure
50%
Ejection Fraction
16%
Coronary Artery Disease
16%
New York Heart Association Class
16%
Angina pectoris
16%
Ischemia
16%
End-Diastolic Volume
16%
Vasodilator Agent
16%
Mean Arterial Pressure
16%
Radionuclide Ventriculography
16%
Heart Left Ventricle Enddiastolic Pressure
16%
Contractile Function
16%
Phosphodiesterase Inhibitor
16%
Afterload
16%
Heart Preload
16%
Heart Muscle Oxygen Consumption
16%
Nursing and Health Professions
Systolic Blood Pressure
100%
Congestive Heart Failure
100%
Enoximone
100%
Heart Left Ventricle Pressure
50%
Catheter
16%
Coronary Artery Disease
16%
Mean Arterial Pressure
16%
Heart Ejection Fraction
16%
Ischemia
16%
Radionuclide Ventriculography
16%
New York Heart Association Class
16%
Heart Left Ventricle Volume
16%
Nitroprusside Sodium
16%
Vasodilator Agent
16%
Heart Afterload
16%
Heart Preload
16%
Heart Left Ventricle Enddiastolic Pressure
16%
Heart Left Ventricle Enddiastolic Volume
16%
Heart Left Ventricle dP-dt
16%
Phosphodiesterase Inhibitor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Enoximone
100%
Coronary Artery Disease
16%
Ischemia
16%
Nitroprusside Sodium
16%
Vasodilator Agent
16%
Phosphodiesterase Inhibitor
16%